Eur Rev Med Pharmacol Sci 2023; 27 (11): 5119-5127
DOI: 10.26355/eurrev_202306_32628

Intravenous N-acetylcysteine in respiratory disease with abnormal mucus secretion

W. Tang, D. Zhu, F. Wu, J.-F. Xu, J.-P. Yang, Z.-P. Deng, X.-B. Chen, A. Papi, J.-M. Qu

Department of Pulmonary and Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. jmqu0906@163.com


OBJECTIVE: Evidence for the mucolytic and expectorant efficacy of intravenous (IV) N-acetylcysteine (NAC) is limited. This study aimed to evaluate in a large, multicenter, randomized, controlled, subject, and rater-blinded study whether IV NAC is superior to placebo and non-inferior to ambroxol in improving sputum viscosity and expectoration difficulty.

PATIENTS AND METHODS: A total of 333 hospitalized subjects from 28 centers in China with respiratory disease (such as acute bronchitis, chronic bronchitis and exacerbations, emphysema, mucoviscidosis, and bronchiectasis) and abnormal mucus secretion were randomly allocated in a 1:1:1 ratio to receive NAC 600 mg, ambroxol hydrochloride 30 mg, or placebo as an IV infusion twice daily for 7 days. Mucolytic and expectorant efficacy was assessed by ordinal categorical 4-point scales and analyzed by stratified and modified Mann-Whitney U statistics.

RESULTS: NAC showed consistent and statistically significant superiority to placebo and non-inferiority to ambroxol in change from baseline to day 7 in both sputum viscosity scores [mean (SD) difference 0.24 (0.763), p<0.001 vs. placebo] and expectoration difficulty score [mean (SD) difference 0.29 (0.783), p=0.002 vs. placebo]. Safety findings confirm the good tolerability profile of IV NAC reported from previous small studies, and no new safety concerns were identified.

CONCLUSIONS: This is the first large, robust study of the efficacy of IV NAC in respiratory diseases with abnormal mucus secretion. It provides new evidence for IV NAC administration in this indication in clinical situations where the IV route is preferred.

Free PDF Download

To cite this article

W. Tang, D. Zhu, F. Wu, J.-F. Xu, J.-P. Yang, Z.-P. Deng, X.-B. Chen, A. Papi, J.-M. Qu
Intravenous N-acetylcysteine in respiratory disease with abnormal mucus secretion

Eur Rev Med Pharmacol Sci
Year: 2023
Vol. 27 - N. 11
Pages: 5119-5127
DOI: 10.26355/eurrev_202306_32628